Oncology Imaging: Archives News of the month
The value of 18F-FDG PET/CT and 18F-DOPA PET/CT in determining the initial surgical strategy of patients with medullary thyroid cancer
Oncology Imaging 6 min.
The only way to reach complete curation in patients with localized medullary thyroid carcinoma (MTC) is through comprehensive high-quality surgery with removal of the affected thyroid and lymph node metastases (LNM). Treatment guidelines recommend a total thyroidectomy in all patients since both thyroid...
Identification of a novel hypermethylation marker, ZSCAN18, and construction of a diagnostic model in cervical cancer
Oncology Imaging 6 min.
Cervical cancer (CC) is the fourth most common malignancy in women worldwide [1]. In 2022, there were approximately 661,021 new cases of CC and 348,189 deaths worldwide, and there were 150,659 new cases of CC and 55,694 deaths in China[2], and the age of onset of CC is progressively younger[3], which...
An interpretable machine learning model based on computed tomography radiomics for predicting programmed death ligand 1 expression status in gastric cancer
Oncology Imaging 6 min.
Gastric cancer (GC) is the fifth most common malignancy and the fourth leading cause of cancer-related death worldwide [1]. GC typically has a poor prognosis because it is often diagnosed at an advanced stage [2]. Despite several recent advancements in relevant surgical techniques, neoadjuvant chemotherapy,...
Comparative diagnostic performance of VI-RADS based on biparametric and multiparametric MRI in predicting muscle invasion in bladder cancer
Oncology Imaging 4 min.
Bladder cancer is a common malignant tumor of the urinary tract [1]. Compared to non-muscle-invasive bladder cancer (NMIBC), muscle-invasive bladder cancer (MIBC) exhibits greater aggressiveness and has a poorer prognosis [2]. Currently, the diagnosis of MIBC is dependent on diagnostic transurethral...
Dual-phase contrast-enhanced CT-based intratumoral and peritumoral radiomics for preoperative prediction of lymph node metastasis in gastric cancer
Oncology Imaging 5 min.
Gastric cancer is the fifth most common malignant tumor and the third cause of cancer-related death in the world [1, 2]. At present, radical tumor resection is still the main treatment for resectable gastric cancer [3, 4–5]. Despite the improvement of adjuvant therapy, the postoperative survival...
